This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE).
Everything from finding discounts for expensive medications to figuring out how to get to their many doctor’s appointments; for these patients to succeed, they need a simplification and streamlining of all of this, preferably in one place. Having the right tools, like digital platforms, is a game-changer.
Despite physicians conducting an average of six professional searches every working day, only 17% of them searched with the words “pharmaceuticalmanufacturers.” Helpfully, Google conducted research to work out how healthcare professionals were sourcing products online.
A new water-based reactor system, developed by scientists at Rice University, promises to bring significant advances to pharmaceuticalmanufacturing. They enable chemical transformations that wouldnt normally work in water while being more sustainable than traditional methods.
Doctors, caregivers, life sciences companies, and even companies in other industries have attempted to answer this question for as long as medications have been available. Launched in July 2021, Prescryptive Health provides next-generation, mobile market access and medication adherence solutions for pharmaceuticalmanufacturers.
They point to an unmissable opportunity for pharmaceuticalmanufacturers and their media partners to create impact where it matters most—at time of prescribing. This is an achievable reality through strategic use of existing healthcare channels that have been negotiated for pharma access—inside the electronic health record (EHR).
It is noteworthy that Malaysia has a pharmaceuticalmanufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% of gross domestic product (GDP). I also note that the five largest companies typically sell originator drugs and account for 47 percent of total drug imports.
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceuticalmanufacturing. Defossilization of pharmaceuticalmanufacturing.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content